Inflammation
KPV, low-dose naltrexone and how the inflammation evidence compares.
KPV peptide: benefits, side effects and what the research shows
What the KPV peptide is, what people use it for, what the inflammation research shows (mostly cell and mouse colitis studies), what is known and unknown about side effects, how oral delivery has been studied, and why KPV keeps turning up in peptide stacks and blends. Every claim is sourced.
Does KPV peptide fight cancer? Checking the claims against what was published
A myth-vs-evidence check of the KPV peptide cancer claims: the one mouse study behind them, what it did and did not show, why unrelated "KPV" papers turn up in cancer searches, whether KPV could cause cancer, and how it differs from Melanotan II. Every claim is sourced.
LDN vs peptides for inflammation: what actually has evidence?
A plain-English, primary-sourced comparison of low-dose naltrexone (LDN) and research peptides for chronic inflammatory conditions: what each one is, how strong the human evidence really is, what side effects have been measured, and why the two are not interchangeable.
KPV peptide capsules: what the oral research covers and what it does not
KPV capsules are the newest product in gut-focused peptide routines. This explainer walks through the oral-delivery research behind them (the PepT1 uptake paper, nanoparticle and prodrug studies in mice), what that research never tested, and what is and is not known about safety. Every claim is sourced.